As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval.
Source: [MIT Tech Review](https://www.technologyreview.com/2026/07/30/1140942/montana-experimental-medical-hub-pushed-forward-right-to-try/)